SHS Capital is a leading German healthcare-dedicated private equity and growth capital firm based in Tübingen, founded in 1993. It invests in fast-growing healthcare companies across MedTech, Life Sciences, Diagnostics, and Digital Health, supporting them to become European healthcare champions.
38% of their portfolio is in Biotech & Life Sciences.
Portfolio
7
Fund Size
$292M
Top Stage
Series A
Last 12 Mo
0
Team
Marie Dechenoix
Investment Manager
Portfolio Breakdown
Stage Distribution
Investment Activity
Portfolio
8 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Salvia BioElectronics | Series B | $60M | May 2025 |
| NNeuro Event Labs Oy | Series A | — | Feb 2025 |
| IIncision Group B.V. | Series A | — | May 2021 |
 Neuro Event Labs | Series A | — | — |
 Pathoquest | Series B | — | — |
| GGNA Biosolutions GmbH | Series C | $13.5M | — |
| GGNA Biosolutions GmbH | Series B | — | — |
| SSimulands AG | Unknown | — | — |
Top Co-Investors
Maki.vc2 shared
Hadean Ventures2 shared
SHS2 shared
Robert Bosch Venture Capital2 shared
European Commission1 shared
Eurazeo1 shared
Verve Ventures1 shared
Kurma Partners1 shared
Rubio Impact Ventures1 shared
UVC Partners1 shared
KfW1 shared
b-to-v Partners1 shared
Dolby Family Ventures1 shared
Sofinnova Partners1 shared
Thuja Capital1 shared
Invest-NL1 shared
OSS Capital1 shared
Innovation Industries1 shared
Last updated: 19 September 2026